ROSG Related
-
Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference
-
Rosetta Genomics (ROSG) Higher After Credentialing Agreement w/Prime Health
-
Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2
-
Traders Jump on Gene Plays (ROSG) (GENE) on Angelina Jolie Mastectomy News
-
Rosetta Genomics (ROSG) Sees Mid-Day Upside
-
Sanra Pays Full Settlement to Rosetta (ROSG)
-
Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories
-
Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting
-
Rosetta Genomics (ROSG) Enters Settlement with Sanra Labs
-
Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
-
Sidoti Downgrades Rosetta Genomics (ROSG) to Neutral
-
Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
-
Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology
-
Rosetta Genomics To Host Business Update Conference Call on April 10, 2013
-
Rosetta Genomics (ROSG) Receives Two U.S. Patents for microRNAs, miRNAs
-
Unusual 11 Mid-Day Movers 01/09: (ININ) (KGJI) (CSIQ) Higher; (SCHS) (PPHM) (NUVA) Lower
-
Rosetta Genomics (ROSG) Highlights Study on MicroRNA Expression
-
Rosetta Genomics (ROSG) Elects Yitzhak Peterburg as Class I Director
-
Rosetta Genomics (ROSG) Shares Active Early on Volume
-
Unusual 11 Mid-Day Movers 11/06: (NVGN) (FN) (ENOC) Higher; (THQI) (SREV) (SYPR) Lower
-
Rosetta Genomics (ROSG), PTI Launch miRview mets2 Assay in U.S. Market
-
Rosetta Genomics (ROSG) Falls Back Below Recent Support Level on Block Trade
-
Pre-Open Movers 8/24: (ARUN) (MSG) (LLY) Higher; (ADSK) (GGP) (CRM) Lower (more...)
-
Rosetta Genomics (ROSG) Continues Higher on Positive Analyst Coverage, Strong Cash Position
-
Unusual 11 Mid-Day Movers 08/23: (ROSG) (HAIN) (TWER) Higher; (BIG) (GES) (SAND) Lower
-
Morning Movers 08/23: (HAIN) (CALX) (TWER) Higher; (BIG) (GES) (BWEN) Lower
-
Notable Analyst Rating Changes 08/23: (ANH) (CS) (LMNX) Upgraded; (X) (NOC) (SWY) Downgraded
-
Pre-Open Movers 8/23: (ROSG) (PSUN) (HAIN) Higher; (GES) (BIG) (DLLR) Lower (more...)
-
UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside
-
Rosetta Genomics (ROSG) Hires Three New Execs, Expands Commercial Ops
-
Rosetta Genomics (ROSG) Closes 5.5M Offering at $5/Share
-
Rosetta Genomics (ROSG) Prices 5.5M Common Offering at $5/Share
-
Rosetta Genomics (ROSG), Precision Therapeutics Enter miRview Co-Marketing Agreement
-
Rosetta Genomics (ROSG) Finalizes Termination of IP Agreement with Avatao Biotech
-
Rosetta Genomics (ROSG) Rips Higher
-
Genetic Tech (GENE), Rosetta (ROSG), Pacific Biosciences (PACB) Follow Complete Genomics (GNOM) Higher
-
Rosetta Genomics (ROSG) Pops on New Patent for Liver Cancer
-
Rosetta Genomics (ROSG) Reports Publication of Data from miRview Lung Assay
-
Rosetta Genomics (ROSG) is On the Move
-
Rosetta Genomics (ROSG) Announces NY State Approval for miRview Lung
-
UPDATE: Rosetta Genomics (ROSG) Files to Offer Up to $35M in Shares
-
After-Hours Movers 06/25: (STX) (APOL) Higher; (ROSG) (SNX) Lower
-
Rosetta Genomics (ROSG) Pays Off Secured Loan, Reclaims Unencumbered Rights to Assets
-
Pre-Open Winners 6/20: (WSCI) (GEVO) (IDIX) (more...)
-
Rosetta Genomics (ROSG) Secures Medicare Reimbursement Pricing for miRv
-
Traders 'Smell' Rosetta Genomics (ROSG) Secondary
-
Streetinsider.com's Hot Lunchtime Reads 06/18: (FB) (ROSG) (AAPL) (X) (IOC) (AET)
-
Traders Witness Possible Short Squeezes in ROSG and OSIR
-
Genetic Tech. (GENE), Complete Genomics (GNOM) See Profit-Taking Following Positive Cancer Report
-
Unusual 11 Mid-Day Movers 06/14: (NBG) (GMO) (JASO) Higher; (NOK) (EGT) (LSCC) Lower
Back to ROSG Stock Lookup
